By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enigma Diagnostics today said that it plans to seek regulatory approval in the US for its molecular influenza assay in 2012.

In support of its submission, the company has started clinical trials for its point-of-care Enigma ML Influenza A/B detection assay.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.